CDDO to Treat Solid Tumors and Lymphomas

NCT00322140 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

NIH

Sponsor class

Conditions

Solid Tumors
Lymphoma

Interventions

DRUG: CDDO

Sponsor

National Cancer Institute (NCI)